TOCOX?A randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk

2005 ◽  
Vol 112 (6) ◽  
pp. 725-730 ◽  
Author(s):  
Katie M. Groom ◽  
Andrew H. Shennan ◽  
Bryony A. Jones ◽  
Paul Seed ◽  
Phillip R. Bennett
Keyword(s):  
High Risk ◽  
Preterm Delivery ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Prostaglandin Inhibitor ◽  
Cox 2

Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder

2007 ◽  
Vol 68 (05) ◽  
pp. 781-788 ◽  
Author(s):  
Robert L. Findling ◽  
Thomas W. Frazier ◽  
Eric A. Youngstrom ◽  
Nora K. McNamara ◽  
Robert J. Stansbrey ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
High Risk ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2020 ◽  
Vol 395 (10220) ◽  
pp. 285-293 ◽  
Author(s):  
Matthew K Hoffman ◽  
Shivaprasad S Goudar ◽  
Bhalachandra S Kodkany ◽  
Mrityunjay Metgud ◽  
Manjunath Somannavar ◽  
...  
Keyword(s):  
Preterm Delivery ◽  
Low Dose ◽  
Controlled Trial ◽  
Singleton Pregnancy ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Aspirin ◽  
Nulliparous Women ◽  
Low Dose Aspirin
Sign in / Sign up

Export Citation Format

Share Document